✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Taisho Pharmaceutical Holdings Co Ltd (Pre-Merger)

Common Name
Taisho Pharmaceutical
Country
Japan
Sector
N/A
Industry
N/A
Employees
N/A
Ticker
4581
Exchange
TOKYO STOCK EXCHANGE

Taisho Pharmaceutical's Climate Target Data Preview

As of 2023, Taisho Pharmaceutical has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 absolute reduction target, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Taisho Pharmaceutical's climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target*
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy/Paste is a PRO feature.
a
2030
*. This target is limited in scope and does not represent the company's full operational or organizational boundaries
Limited Data Preview
You are viewing a limited preview of Taisho Pharmaceutical’s Climate Target dataset. The full dataset, available for download, includes detailed baseline information for both absolute and intensity targets, along with reported progress and achievement details as of 2023.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Taisho Pharmaceutical’s Climate Targets Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Taisho Pharmaceutical’s data sources below and access millions more through our Disclosure Search.

a. Taisho Pharmaceutical's Webpage captured from company’s website 2023

Insights into Taisho Pharmaceutical's Greenhouse Gas Emissions Pathways

As of 2023, Taisho Pharmaceutical has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.a

Does Taisho Pharmaceutical have a target to reduce the emissions from its operations?

As of 2023, Taisho Pharmaceutical has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.a

Taisho Pharmaceutical's most ambitious operational target is to reduce these emissions by 46% by 2030, compared to a baseline of 56,263 Metric Tonnes of CO2 equivalent (mtCO2e) in 2013.a

As of 2022, Taisho Pharmaceutical is lagging behind on its operational emissions reduction target, having achieved 23.26% of the planned reduction.a

Taisho Pharmaceutical's Operational (Scope 1+2) Emissions Pathway

201320222030015 k30 k45 k60 kBaselineCurrent (-11%)Target 2030 (-46%)
Want Full Access to Taisho Pharmaceutical's Climate Targets Dataset?
Start 30-Day Free Trial